Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Science. 2023 Dec 15;382(6676):1270-1276. doi: 10.1126/science.adg0514. Epub 2023 Dec 14.
Current HIV vaccines designed to stimulate CD8 T cells have failed to induce immunologic control upon infection. The functions of vaccine-induced HIV-specific CD8 T cells were investigated here in detail. Cytotoxic capacity was significantly lower than in HIV controllers and was not a consequence of low frequency or unaccumulated functional cytotoxic proteins. Low cytotoxic capacity was attributable to impaired degranulation in response to the low antigen levels present on HIV-infected targets. The vaccine-induced T cell receptor (TCR) repertoire was polyclonal and transduction of these TCRs conferred the same reduced functions. These results define a mechanism accounting for poor antiviral activity induced by these vaccines and suggest that an effective CD8 T cell response may require a vaccination strategy that drives further TCR clonal selection.
目前设计用于刺激 CD8 T 细胞的 HIV 疫苗未能在感染时诱导免疫控制。本文详细研究了疫苗诱导的 HIV 特异性 CD8 T 细胞的功能。细胞毒性能力明显低于 HIV 控制器,并且不是由于低频或未积累功能细胞毒性蛋白所致。低细胞毒性能力归因于对 HIV 感染靶标上存在的低抗原水平的脱颗粒受损。疫苗诱导的 T 细胞受体 (TCR) 库是多克隆的,并且这些 TCR 的转导赋予了相同的降低的功能。这些结果定义了一个解释这些疫苗诱导的抗病毒活性差的机制,并表明有效的 CD8 T 细胞反应可能需要一种疫苗接种策略,该策略可进一步驱动 TCR 克隆选择。